Definition of "experimental procedures"

被引：8

作者：

Fritz, Marc A.

Ory, Steven J.

Barnhart, Kurt T. ^{[2
,3
]}

Catherino, William H.

Cedars, Marcelle I.

Collins, John

Goldberg, Jeffrey M.

Gracia, Clarsia ^{[4
]}

Licht, Mark

Liu, James H. ^{[5
,6
,7
]}

Racowsky, Catherine

Schattman, Glenn

Thomas, Michael. A. ^{[8
,9
]}

Rebar, Robert W.

La Barbera, Andrew R.

机构：

[1] Amer Soc Reprod Med, Birmingham, AL USA

[2] Xanodyne Pharmaceut Inc, Newport, KY USA

[3] Third Wave Technol Inc, Madison, WI USA

[4] Pfizer Inc, New York, NY USA

[5] Boebringer Ingelheim GmbH, Ingelheim, Germany

[6] Teva Pharmaceut USA, N Wales, PA USA

[7] Solvay Pharmaceut Inc, Marietta, GA USA

[8] Watson Pharmaceut Inc, Corona, CA USA

[9] Bayer HealthCare, Tarrytown, NY USA

来源：

FERTILITY AND STERILITY | 2009年 / 92卷 / 05期

关键词：

D O I：

10.1016/j.fertnstert.2009.08.060

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

This Practice Committee Opinion provides a revised definition of "experimental procedures." This version replaces the document "Definition of Experimental" that was published most recently in November 2008. (Fertil Steril (R) 2009;92:1517. (C) 2009 by American Society for Reproductive Medicine.)

引用

页码：1517 / 1517

页数：1